Gonadotropin-releasing hormone antagonists increase follicular fluid insulin-like growth factor-I and vascular endothelial growth factor during ovarian stimulation cycles

Gynecological Endocrinology

Volumn 22, Issue 6, 2006, Pages 289-296

  Ferrari, Bruno ^a   Pezzuto, Antonio ^a   Barusi, Lorenzo ^a   Coppola, Francesco ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Controlled ovarian hyperstimulation; Gonadotropin releasing hormone antagonist; Insulin like growth factor I; Luteinizing hormone; Vascular endothelial growth factor

Indexed keywords

ANDROSTENEDIONE; CETRORELIX; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LEUPRORELIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; SOMATOMEDIN C; VASCULOTROPIN;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONAL REGULATION; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY FOLLICLE FLUID; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCTION; TREATMENT OUTCOME;

ADULT; ANDROSTENEDIONE; CHORIONIC GONADOTROPIN; ESTRADIOL; FEMALE; FOLLICULAR FLUID; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY; INSULIN-LIKE GROWTH FACTOR I; LEUPROLIDE; LUTEINIZING HORMONE; OVULATION INDUCTION; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33745351854     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590600777602     Document Type: Article

References (52)

1. Al-Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 2002;17:874-885.
2. European and Middle East Orgalutran Study Group. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 2001;16:644-651.
3. Albano C, Felberbaum RE, Smitz J, Riethmuller-Winzen H, Engel J, Diedrich K, Devroey P. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod 2000;15:526-531.
4. Fasouliotis SJ, Laufer N, Sabbagh-Ehrlich S, Lewin A, Hurwitz A, Simon A. Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF. J Assist Reprod Genet 2003;20:455-460.
5. Borm G, Mannaerts B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod 2000;15:1490-1498.
6. Hernandez ER. Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod 2000;15:1211-1216.
7. Kol S. Embryo implantation and GnRH antagonists: GnRH antagonists in ART: lower embryo implantation? Hum Reprod 2000;15:1881-1882.
8. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
9. Risau W. Mechanism of angiogenesis. Nature 1997;386:671-674.
10. Gupta K, Kshirsagar S, Li W, Gui L, Ramakrishna S, Gupta P, Law P, Hebbel RP. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res 1999;247:495-504.
11. Volm M, Mattem J, Koomagi R. Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinomas. Anticancer Res 1999;19:1669-1671.
12. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC. The insulin-related ovarian regulatory system in health and disease. Endocr Rev 1999;20:535-582.
13. Monget P, Bondy C. Importance of the IGF in early folliculogenesis. Mol Cell Endocrinol 2000;163:89-93.
14. El-Roeiy A, Chen X, Roberts VJ. Expression of insulin-like growth factor-I (IGF-I) and IGF II, and the IGF I, IGF II, and insulin receptor genes and localizations of the genes products in the human ovary. J Clin Endrocrinol Metab 1993;77:1411-1418.
15. Zhou J, Bondy CA. Anatomy of the human ovarian insulin-like growth factor system. Biol Reprod 1993;48:467-482.
16. Menashe Y, Sack J, Mashiach S. Spontaneous pregnancies in two women with Laron-type dwarfism: are growth hormone and circulating insulin-like growth factor mandatory for induction of ovulation? Hum Reprod 1991;6:670-671.
17. Dor J, Ben-Shlomo I, Lunenfeld B, Pariente C, Levran D, Karasik A, Seppala M, Mashiach S. Insulin-like growth factor-I (IGF-I) may not be essential for ovarian follicular development: evidence from IGF-I deficiency. J Clin Endocrinol Metab 1992;74:539-542.
18. Spiliotis BE. Growth hormone insufficiency and its impact on ovarian function. Ann N Y Acad Sci 2003;997:77-84.
19. Tesarik J, Hazout A, Mendoza C. Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone. Hum Reprod 2005;20:2536-2541.
20. World Health Organization. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 3rd edn. Cambridge: Cambridge University Press; 1992. pp 1-107.
21. Geva E, Jaffe RB. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 2000;74:429-439.
22. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9-22.
23. Friedman CI, Seifer DB, Kennard EA, Arbogast L, Alak BM, Danforth DR. Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential. Fertil Steril 1998;70:836-839.
24. Battaglia C, Genazzani AD, Regnani G, Primavera MR, Petraglia F, Volpe A. Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders. Fertil Steril 2000;74:809-812.
25. Ocal P, Aydin S, Cepni I, Idil S, Idil M, Uzun H, Benian A. Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome? Eur J Obstet Gynecol Reprod Biol 2004;115:194-199.
26. Friedman CI, Danforth DR, Herbosa-Encarnacion C, Arbogast L, Alak BM, Seifer DB. Follicular fluid vascular endothelial growth factor concentrations are elevated in women of advanced reproductive age undergoing ovulation induction. Fertil Steril 1997;68:607-612.
27. Klein NA, Battaglia DE, Woodruff TK, Padmanabhan V, Giudice LC, Bremner WJ, Soules MR. Ovarian follicular concentrations of activin, follistatin, inhibin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-2 (IGFBP-2), IGFBP-3, and vascular endothelial growth factor in spontaneous menstrual cycles of normal women of advanced reproductive age. J Clin Endocrinol Metab 2000;85:4520-4525.
28. Barroso G, Barrionuevo M, Rao P, Graham L, Danforth D, Huey S, Abuhamad A, Oehninger S. Vascular endothelial growth factor, nitric oxide, and leptin follicular fluid levels correlate negatively with embryo quality in IVF patients. Fertil Steril 1999;72:1024-1026.
29. Quintana R, Kopcow L, Marconi G, Sueldo C, Speranza G, Barañao RI. Relationship of ovarian stimulation response with vascular endothelial growth factor and degree of granulosa cell apoptosis. Hum Reprod 2001;16:1814-1818.
30. Taylor PD, Hillier SG, Fraser HM. Effects of GnRH antagonist treatment on follicular development and angiogenesis in the primate ovary. J Endocrinol 2004;183:1-17.
31. Basini G, Bianco F, Grasselli F, Tirelli M, Bussolati S, Tamanini C. The effects of reduced oxygen tension on swine granulosa cell. Regul Pept 2004;120:69-75.
32. Martinez-Chequer JC, Stouffer RL, Hazzard TM, Patton PE, Molskness TA. Insulin-like growth factors-1 and -2, but not hypoxia, synergize with gonadotropin hormone to promote vascular endothelial growth factor-A secretion by monkey granulosa cells from preovulatory follicles. Biol Reprod 2003;68:1112-1118.
33. Slomiany MG, Rosenzweig SA. Autocrine effects of IGF-1 induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19. Am J Physiol Cell Physiol 2004;287:C746-C753.
34. Chavez JC, LaManna JC. Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1. J Neurosci 2002;15:8922-8931.
35. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL. Insulin-like growth factor 1 induces hypoxia-inducible factor1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 2002;277:38205-38211.
36. Guan J, Bennet L, Gluckman PD, Gunn AJ. Insulin-like growth factor-1 and post-ischemic brain injury. Prog Neurobiol 2003;70:443-462.
37. Beilharz EJ, Russo VC, Butler G, Baker NL, Connor B, Sirimanne ES, Dragunow M, Werther GA, Gluckman PD, Williams CE, et al. Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. Mol Brain Res 1998;59:119-134.
38. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. Activation of vascular growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996;16:4604-4613.
39. Louhio H, Hovatta O, Sjöberg J, Tuuri T. The effects of insulin, and insulin-like growth factors I and II on human ovarian follicles in long-term culture. Mol Hum Reprod 2000;6:694-698.
40. Quirk SM, Cowan RG, Harman RM, Hu CL, Porter DA. Ovarian follicular growth and atresia: the relationship between cell proliferation and survival. J Anim Sci 2004;82:E40-E52.
41. Coppola F, Potì E, Ferrari, B Barusi L, Salvarani MC, Vadora E. Profound luteinizing hormone suppression induces deleterious follicular environment during assisted reproduction technology. Fertil Steril 2003;79:459-460.
42. Richards JS, Jongssen JA, Kersey KA. Evidence that changes in tonic luteinizing hormone secretion determine the growth of preovulatory follicles in the rat. Endocrinology 1980;107:641-648.
43. Hiller SG. Gonadotrophic control of ovarian follicular growth and development. Mol Cell Endocrinol 2001;179:39-46.
44. Bogovich K, Richards JS. Androgen biosynthesis in developing ovarian follicle: evidence that luteinizing hormone regulates theca 17α- hydroxylase and C17-20 lyase activity. Endocrinology 1982;111:1201-1208.
45. Harman SM, Louvet JP, Ross GT. Interaction of estrogen and gonadotropins on follicular atresia. Endocrinology 1975;96:1145-1152.
46. Tesarik J, Mendoza C. Nongenomic effects of 17β-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol Metab 1995;80:1438-1443.
47. Tesarik J, Mendoza C. Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence. Hum Reprod 2002;17:3129-3137.
48. Reilly CM, Cannady WE, Mahesh VB, Stopper VS, De Sevilla LM, Mills TM. Duration of estrogen exposure prior to FSH stimulation critical to granulosa cell growth and differentiation in rats. Biol Reprod 1996;54:1336-1343.
49. Garcia-Velasco JA, Isaza V, Vidal C, Landazabal A, Remohi J, Simon C, Pellicer A. Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix). Hum Reprod 2001;16:2533-2539.
50. Acevedo B, Sanchez M, Gomez JL, Cuadros J, Ricciarelli E, Hernandez ER. Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles. Fertil Steril 2004;82:343-347.
51. Oussaid B, Lonergan P, Khatir H, Guler A, Monniaux D, Touze JL, Beckers JF, Cognie Y, Mermillod P. Effect of GnRH antagonist-induced prolonged follicular phase on follicular atresia and oocyte developmental competence in vitro in superovulated heifers. Reprod Fertil 2000;118:137-144.
52. Ferrari B, Barusi L, Lanna M, Coppola F. Ovarian response and pregnancy outcome related to midfollicular LH levels in down-regulated women undergoing assisted reproduction. Reprod Med 2004;49:148-152.